T15EXPLORING THE GENETIC ARCHITECTURE OF CO-OCCURRING SYMPTOMS IN AUTISM

Marjolein van Donkelaar(Max Planck Institute for Psycholinguistics), Beaté St Pourcain(University of Bristol), Dheeraj Rai(Avon and Wiltshire Mental Health Partnership NHS Trust), Ellen Verhoef(Max Planck Institute for Psycholinguistics), Celeste Figaroa(Max Planck Institute for Psycholinguistics), Simon E. Fisher(Radboud University Nijmegen)
European Neuropsychopharmacology
September 27, 2019
10.1016/j.euroneuro.2019.08.214
Cited by 0

Related Papers

Identification of common genetic risk variants for autism spectrum disorder
|Nature Genetics|2019|2.6k
Mental health before and during the COVID-19 pandemic in two longitudinal UK population cohorts
|The British Journal of Psychiatry|2020|533
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia
|Nature Genetics|2013|485
Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study
|BMJ|2013|370
Identification of heart rate–associated loci and their effects on cardiac conduction and rhythm disorders
|Nature Genetics|2013|324